LoginSignup
profile image
Paul
@paul_finesse_
1Mon·

Good morning dear community,


I've been busy building up my portfolio recently and would now like to present my final selection.


Briefly about me, I am 23 years old and used to gamble with a lot of penny stocks. After I suffered a major loss last year, I stopped doing that and have been building up a growth-oriented portfolio for the last few months or am still in the process of investing in all stocks.


My investment horizon is long (at least 20 years plus), as I only invest money that is not needed. A corresponding cash position is available to be able to react to private matters.


Now to the portfolio:

As mentioned above, I follow a more classic buy and hold strategy, which is made up of growth-oriented stocks and some gold as another asset class for admixture.


My ETFs are currently saved through standing orders with a corresponding weighting.


My largest position is the $IWDA (+0.56%) This is constantly being saved with the highest weighting and, together with my $EIMI (+0.23%) a long-term basic investment and broad diversification in developed markets.

Added to this is the $CSNDX (+1.07%) as I continue to focus on technology growth in the long term and am therefore invested in many interesting future-oriented companies.


Nevertheless, Europe should not be neglected and is also important for my diversification. To this end, I have selected $LU0224105477 selected. I chose this fund because it performs better in the benchmark test than other common Europe ETFs (measured over the entire term).

As mentioned above, I also have a small gold investment through $WGLD (+0.65%) .


Finally, we come to my equities:

$PLTR (+5.77%) , definitely an up-and-coming growth company for me in the area of Big Data and AI, (I've also been on board here since the beginning of this year).

$OR (+3.25%) and $NOVO B (-0.05%) were added to the portfolio because they are two strong market leaders in the consumer staples and healthcare sectors, which are fundamentally well positioned and, in my view, will bring long-term growth with corresponding quality through constant new innovations and developments. This allows me to diversify further by sector and country.

$RACE (-1.59%) For me, this is a long-term runner from Italy. Thanks to its strong brand and exclusivity, Ferrari can separate itself from other car manufacturers and, for me, is a share with constant growth and secure profitability.

In the future, I would also like to invest in Japan as a percentage. Here I have placed my bet on a share with a large industry positioning, which can also be regarded as a qualitative long-term runner. It is $8001 (-1.91%) .

$NU (+3.59%) an up-and-coming fintech company that still has strong growth ahead of it. Nu Holdings has made an established name for itself and has also achieved significant fundamental successes and is aiming for further expansion. For me, this is an in-depth risk investment alongside Palantir, which I can enter into and am positive about.

Finally $OCGN (+1.39%) . Ocugen is a biotechnology company for innovative gene therapies for the treatment of eye diseases. The share dates back to the earlier gambling days (Corona hype). I missed the jump back then and have been stuck here since 2020. Unfortunately, I have no further involvement with the investment and am considering selling and investing elsewhere (opportunity) or simply sitting it out until I return to profit.


That was my more or less "brief" portfolio presentation.


Perhaps I have been able to generate new ideas for some of you and I would be happy to receive feedback or stocks that I could include in the future or that I should take a closer look at.


Have a nice weekend everyone.

12Positions
€23,995.29
2.68%
8
10 Comments
Julian@MoneyISnotREAL
1Mon
Nice portfolio presentation and it's remarkable that you're thinking about your future at the age of 23 and are already investing now.

I can understand your thoughts on the combination of ETFs.
World ETF with EM and NASDAQ as a booster, since you are convinced of technology yourself.

Of course, Europe or something like Japan will then fall behind, as you are overweighting the USA. With the Europe fund, you are reweighting it to the NASDAQ in the same proportion as in the world ETF, except that you then completely underweight / "throw out" something like Japan.

Furthermore, I critically question whether the <security:n/a:LU0224105477> is really better. 1.8% running costs p.a.
-Why not a Stoxx 600 ETF, or something like
something like Momentum/Quality-Europe?

-Which benchmark did you compare your fund with? Due to the costs, the fund must ALWAYS generate >2% more return, which is logically not possible if it includes the same stocks - unless it takes on a larger cluster risk of individual stocks.

Regarding your individual stocks, it looks like you have thought about why you want them.

In short:
Carry on like this and strongly reconsider the Europe fund.
•
2
•
Julian@MoneyISnotREAL
1Mon
@MoneyISnotREAL Initial investment: € 10,000

Fond: <security:n/a:LU0224105477>

Initial sales charge: 5%
Ongoing charges p.a.: 1,8%
Yield p.a. (10 years): 9.4%

Volume: € 19,600
Costs: € 2,970

____________________

ETF: $XSX6

Issue surcharge: 0%
Ongoing costs p.a.: 0.2%
Yield p.a. (10 years): 6.8%

Volume: € 18,900
Costs: € 280
•
1
•
profile image
Kai@Dividenden-Sammler
1Mon
@MoneyISnotREAL I can fully agree with you. I had the same thoughts about the Europe fund. I think there are better funds or it is one of very few funds whose fund management outperforms the relevant market indices in the long term. It's also still quite new, so you can't say anything about it in the long term. The fees are quite high, which would have to be recouped first
•
1
•
profile image
Paul@paul_finesse_
1Mon
@MoneyISnotREAL, @Dividenden-Sammler, Thank you very much for taking the time to do an evaluation. On the benchmark issue, I had taken the page: extraETF and overlaid the ETFs with the fund. There were probably a few differences on my part or I didn't take into account the accumulating running costs thoroughly enough. I'll take a look at the comment and see whether it wouldn't make more sense to invest in an e.g. $XSX6 or whether I should add one or two individual stocks to my portfolio after checking them myself and thus, in addition to ( $NOVO B, $RACE, $OR ), it would already be sufficient to have a higher weighting in Europe and put the remaining amount into $IWDA.
••
Julian@MoneyISnotREAL
1Mon
@Paulml With pleasure! That's what the platform is for.

And if you ultimately decide in favor of the fund, you have looked into it, weighed up your motives and decided in favor of it.

When it comes to Europe, you can also take a look at something like "Momentum, Quality". You might find it interesting to map Europe a little more.
Or, as you say, include certain individual stocks.

Many roads lead to Rome.
••
profile image
Tenbagger2024@Tenbagger2024
1Mon
@Paulml
I think there are already some undervalued stocks in Europe. Especially in the s and m DAX, good companies have not performed well this year and have even lost ground. They have now become even cheaper as a result. Could of course gain momentum again with a new German government.
(Not an investment recommendation)
Examples would be $AIXA. $GFT $MUM $NEM $D6H
•
1
•
profile image
Paul@paul_finesse_
1Mon
@MoneyISnotREALI'll have time to think about it over the weekend. One positive thing that caught my eye, for example, was $IEFM, where you can think about a reallocation or compare and weigh up the options first.
•
1
•
profile image
Tenbagger2024@Tenbagger2024
1Mon
Compliments, very good portfolio presentation.
I'm not an expert on ETFs, but it's a good decision to invest in them in terms of risk.
You are also quite conservative with individual stocks. Maybe except for Palantir. I don't need to comment on the valuation with a P/E ratio of over 200. And with (only) double-digit growth, it only falls slightly.
Good advice is expensive here and a vote from the community would be interesting.

Otherwise, the ETFs cover almost everything.
Therefore, if you want, you could take some risk with small positions.
Such as in the crypto area with a miner e.g. $IREN etc. Or ETP providers e.g. $DEFI. In my opinion, Micro Strategy is already well valued.

Otherwise something from the biotech sector where drugs are in phase 3.

In the AI area there are some small data analysis companies or companies that are in the infrastructure for data centers

But some of these companies are of course already fully covered by the ETFs.
••
profile image
Paul@paul_finesse_
1Mon
@Tenbagger2024 Thank you for speaking up here too. That's right, you could add two riskier positions to your portfolio in the future. I already had a good nose for Palantir and got in at around €22. I already have a high-risk position in pharmaceuticals at $OCGN. Here I could inform myself about current levels and data, as I had actually already "mentally" written off the position. I will also take a closer look at the stocks you mentioned. :)
••
profile image
Tenbagger2024@Tenbagger2024
1Mon
I saw that Ocugen is developing vaccines. Maybe it was a corona story, because the company doesn't make any profits. That's why I would always be a bit cautious with such companies. But there are drugs about to be approved in ophthalmology, which is perhaps why the share price has risen this year. Perhaps set a lower stop loss here and if the share continues to rise, stick with it and adjust the stop loss occasionally.
The biotech sector is less risky, e.g. $VRTX, which has been making profits and increasing them for years.
It is similar with $CORT
••
Join the conversation
Sign upLogin